362 related articles for article (PubMed ID: 30134146)
21. BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries.
Wang B; Zhang M; Takayama T; Shi X; Roenneburg DA; Kent KC; Guo LW
EBioMedicine; 2015 Nov; 2(11):1650-61. PubMed ID: 26870791
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic targeting of BET protein BRD4 delays murine lupus.
Wei S; Sun Y; Sha H
Int Immunopharmacol; 2015 Dec; 29(2):314-319. PubMed ID: 26590112
[TBL] [Abstract][Full Text] [Related]
23. Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells.
Khan YM; Kirkham P; Barnes PJ; Adcock IM
PLoS One; 2014; 9(4):e95051. PubMed ID: 24759736
[TBL] [Abstract][Full Text] [Related]
24. Nonselective inhibition of the epigenetic transcriptional regulator BET induces marked lymphoid and hematopoietic toxicity in mice.
Lee DU; Katavolos P; Palanisamy G; Katewa A; Sioson C; Corpuz J; Pang J; DeMent K; Choo E; Ghilardi N; Diaz D; Danilenko DM
Toxicol Appl Pharmacol; 2016 Jun; 300():47-54. PubMed ID: 27078884
[TBL] [Abstract][Full Text] [Related]
25. miR-155 Deletion in Mice Overcomes Neuron-Intrinsic and Neuron-Extrinsic Barriers to Spinal Cord Repair.
Gaudet AD; Mandrekar-Colucci S; Hall JC; Sweet DR; Schmitt PJ; Xu X; Guan Z; Mo X; Guerau-de-Arellano M; Popovich PG
J Neurosci; 2016 Aug; 36(32):8516-32. PubMed ID: 27511021
[TBL] [Abstract][Full Text] [Related]
26. Nanog requires BRD4 to maintain murine embryonic stem cell pluripotency and is suppressed by bromodomain inhibitor JQ1 together with Lefty1.
Horne GA; Stewart HJ; Dickson J; Knapp S; Ramsahoye B; Chevassut T
Stem Cells Dev; 2015 Apr; 24(7):879-91. PubMed ID: 25393219
[TBL] [Abstract][Full Text] [Related]
27. Regulation of inflammatory genes in decidual cells: Involvement of the bromodomain and extra-terminal family proteins.
Ajgaonkar S; Hirst JJ; Norris M; Zakar T
PLoS One; 2023; 18(3):e0280645. PubMed ID: 36897880
[TBL] [Abstract][Full Text] [Related]
28. Nerve Excitability and Neuropathic Pain is Reduced by BET Protein Inhibition After Spared Nerve Injury.
Palomés-Borrajo G; Badia J; Navarro X; Penas C
J Pain; 2021 Dec; 22(12):1617-1630. PubMed ID: 34157407
[TBL] [Abstract][Full Text] [Related]
29. Discovery and characterization of bromodomain 2-specific inhibitors of BRDT.
Yu Z; Ku AF; Anglin JL; Sharma R; Ucisik MN; Faver JC; Li F; Nyshadham P; Simmons N; Sharma KL; Nagarajan S; Riehle K; Kaur G; Sankaran B; Storl-Desmond M; Palmer SS; Young DW; Kim C; Matzuk MM
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33637650
[TBL] [Abstract][Full Text] [Related]
30. BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy.
Antolic A; Wakimoto H; Jiao Z; Gorham JM; DePalma SR; Lemieux ME; Conner DA; Lee DY; Qi J; Seidman JG; Bradner JE; Brown JD; Haldar SM; Seidman CE; Burke MA
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32603312
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective effects of targeting BET proteins for degradation with dBET1 in aged mice subjected to ischemic stroke.
DeMars KM; Yang C; Candelario-Jalil E
Neurochem Int; 2019 Jul; 127():94-102. PubMed ID: 30872008
[TBL] [Abstract][Full Text] [Related]
32. Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function.
Cribbs AP; Filippakopoulos P; Philpott M; Wells G; Penn H; Oerum H; Valge-Archer V; Feldmann M; Oppermann U
Front Immunol; 2021; 12():626255. PubMed ID: 33717143
[TBL] [Abstract][Full Text] [Related]
33. BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs.
Borck PC; Guo LW; Plutzky J
Circ Res; 2020 Apr; 126(9):1190-1208. PubMed ID: 32324495
[TBL] [Abstract][Full Text] [Related]
34. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the Ca²⁺-dependent K⁺ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury.
Bouhy D; Ghasemlou N; Lively S; Redensek A; Rathore KI; Schlichter LC; David S
J Neurosci; 2011 Nov; 31(45):16298-308. PubMed ID: 22072681
[TBL] [Abstract][Full Text] [Related]
36.
Nord JA; Wynia-Smith SL; Gehant AL; Jones Lipinski RA; Naatz A; Rioja I; Prinjha RK; Corbett JA; Smith BC
Front Endocrinol (Lausanne); 2022; 13():923925. PubMed ID: 36176467
[TBL] [Abstract][Full Text] [Related]
37. C-C motif chemokine ligand 20 regulates neuroinflammation following spinal cord injury via Th17 cell recruitment.
Hu J; Yang Z; Li X; Lu H
J Neuroinflammation; 2016 Jun; 13(1):162. PubMed ID: 27334337
[TBL] [Abstract][Full Text] [Related]
38. Photoreceptor protection via blockade of BET epigenetic readers in a murine model of inherited retinal degeneration.
Zhao L; Li J; Fu Y; Zhang M; Wang B; Ouellette J; Shahi PK; Pattnaik BR; Watters JJ; Wong WT; Guo LW
J Neuroinflammation; 2017 Jan; 14(1):14. PubMed ID: 28103888
[TBL] [Abstract][Full Text] [Related]
39. Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins.
Wienerroither S; Rauch I; Rosebrock F; Jamieson AM; Bradner J; Muhar M; Zuber J; Müller M; Decker T
Mol Cell Biol; 2014 Feb; 34(3):415-27. PubMed ID: 24248598
[TBL] [Abstract][Full Text] [Related]
40. GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer.
Bevill SM; Olivares-Quintero JF; Sciaky N; Golitz BT; Singh D; Beltran AS; Rashid NU; Stuhlmiller TJ; Hale A; Moorman NJ; Santos CM; Angus SP; Zawistowski JS; Johnson GL
Mol Cancer Res; 2019 Jul; 17(7):1503-1518. PubMed ID: 31000582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
